nodes	percent_of_prediction	percent_of_DWPC	metapath
Terazosin—ABCB1—Methylprednisolone—multiple sclerosis	0.0942	0.232	CbGbCtD
Terazosin—ABCB1—Mitoxantrone—multiple sclerosis	0.0687	0.169	CbGbCtD
Terazosin—ABCB1—Betamethasone—multiple sclerosis	0.0612	0.151	CbGbCtD
Terazosin—ABCB1—Prednisolone—multiple sclerosis	0.0604	0.149	CbGbCtD
Terazosin—ABCB1—Prednisone—multiple sclerosis	0.0571	0.141	CbGbCtD
Terazosin—ABCB1—Dexamethasone—multiple sclerosis	0.0356	0.0878	CbGbCtD
Terazosin—ABCB1—Methotrexate—multiple sclerosis	0.0286	0.0705	CbGbCtD
Terazosin—KCNH7—nervous system—multiple sclerosis	0.00421	0.0865	CbGeAlD
Terazosin—KCNH7—central nervous system—multiple sclerosis	0.00405	0.0833	CbGeAlD
Terazosin—KCNH7—cerebellum—multiple sclerosis	0.00396	0.0814	CbGeAlD
Terazosin—KCNH7—brain—multiple sclerosis	0.00322	0.0661	CbGeAlD
Terazosin—KCNH6—nervous system—multiple sclerosis	0.003	0.0616	CbGeAlD
Terazosin—KCNH6—central nervous system—multiple sclerosis	0.00289	0.0593	CbGeAlD
Terazosin—KCNH6—brain—multiple sclerosis	0.00229	0.0471	CbGeAlD
Terazosin—ADRA1A—brainstem—multiple sclerosis	0.00182	0.0374	CbGeAlD
Terazosin—ADRA1B—nervous system—multiple sclerosis	0.0017	0.0349	CbGeAlD
Terazosin—ADRA1D—nervous system—multiple sclerosis	0.00166	0.0341	CbGeAlD
Terazosin—ADRA1B—central nervous system—multiple sclerosis	0.00163	0.0336	CbGeAlD
Terazosin—ADRA1D—central nervous system—multiple sclerosis	0.0016	0.0329	CbGeAlD
Terazosin—ADRA1B—brain—multiple sclerosis	0.0013	0.0267	CbGeAlD
Terazosin—ADRA1D—brain—multiple sclerosis	0.00127	0.0261	CbGeAlD
Terazosin—KCNH2—medulla oblongata—multiple sclerosis	0.00123	0.0252	CbGeAlD
Terazosin—KCNH2—midbrain—multiple sclerosis	0.00112	0.023	CbGeAlD
Terazosin—KCNH2—spinal cord—multiple sclerosis	0.00109	0.0225	CbGeAlD
Terazosin—ADRA1A—nervous system—multiple sclerosis	0.000954	0.0196	CbGeAlD
Terazosin—KCNH2—nervous system—multiple sclerosis	0.000921	0.0189	CbGeAlD
Terazosin—ADRA1A—central nervous system—multiple sclerosis	0.000918	0.0189	CbGeAlD
Terazosin—ADRA1A—cerebellum—multiple sclerosis	0.000898	0.0185	CbGeAlD
Terazosin—KCNH2—central nervous system—multiple sclerosis	0.000887	0.0182	CbGeAlD
Terazosin—KCNH2—cerebellum—multiple sclerosis	0.000867	0.0178	CbGeAlD
Terazosin—ABCB1—retina—multiple sclerosis	0.000744	0.0153	CbGeAlD
Terazosin—ADRA1A—brain—multiple sclerosis	0.000729	0.015	CbGeAlD
Terazosin—KCNH2—brain—multiple sclerosis	0.000704	0.0145	CbGeAlD
Terazosin—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.00063	0.0016	CcSEcCtD
Terazosin—Convulsion—Methylprednisolone—multiple sclerosis	0.00063	0.0016	CcSEcCtD
Terazosin—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000625	0.00159	CcSEcCtD
Terazosin—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000623	0.00158	CcSEcCtD
Terazosin—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000623	0.00158	CcSEcCtD
Terazosin—Myalgia—Triamcinolone—multiple sclerosis	0.00062	0.00158	CcSEcCtD
Terazosin—Vomiting—Azathioprine—multiple sclerosis	0.00062	0.00158	CcSEcCtD
Terazosin—Arthralgia—Methylprednisolone—multiple sclerosis	0.000619	0.00157	CcSEcCtD
Terazosin—Myalgia—Methylprednisolone—multiple sclerosis	0.000619	0.00157	CcSEcCtD
Terazosin—Eye disorder—Prednisone—multiple sclerosis	0.000618	0.00157	CcSEcCtD
Terazosin—Anxiety—Methylprednisolone—multiple sclerosis	0.000617	0.00157	CcSEcCtD
Terazosin—Rash—Azathioprine—multiple sclerosis	0.000615	0.00156	CcSEcCtD
Terazosin—Dermatitis—Azathioprine—multiple sclerosis	0.000614	0.00156	CcSEcCtD
Terazosin—Depression—Methotrexate—multiple sclerosis	0.000614	0.00156	CcSEcCtD
Terazosin—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000614	0.00156	CcSEcCtD
Terazosin—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000614	0.00156	CcSEcCtD
Terazosin—Discomfort—Triamcinolone—multiple sclerosis	0.000613	0.00156	CcSEcCtD
Terazosin—Discomfort—Methylprednisolone—multiple sclerosis	0.000612	0.00156	CcSEcCtD
Terazosin—Headache—Azathioprine—multiple sclerosis	0.000611	0.00155	CcSEcCtD
Terazosin—Dry mouth—Triamcinolone—multiple sclerosis	0.000607	0.00154	CcSEcCtD
Terazosin—Angioedema—Betamethasone—multiple sclerosis	0.000604	0.00154	CcSEcCtD
Terazosin—Angioedema—Dexamethasone—multiple sclerosis	0.000604	0.00154	CcSEcCtD
Terazosin—Conjunctivitis—Methotrexate—multiple sclerosis	0.000599	0.00152	CcSEcCtD
Terazosin—Confusional state—Methylprednisolone—multiple sclerosis	0.000598	0.00152	CcSEcCtD
Terazosin—Malaise—Betamethasone—multiple sclerosis	0.000596	0.00152	CcSEcCtD
Terazosin—Malaise—Dexamethasone—multiple sclerosis	0.000596	0.00152	CcSEcCtD
Terazosin—Oedema—Triamcinolone—multiple sclerosis	0.000595	0.00151	CcSEcCtD
Terazosin—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000595	0.00151	CcSEcCtD
Terazosin—Vertigo—Betamethasone—multiple sclerosis	0.000594	0.00151	CcSEcCtD
Terazosin—Vertigo—Dexamethasone—multiple sclerosis	0.000594	0.00151	CcSEcCtD
Terazosin—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000593	0.00151	CcSEcCtD
Terazosin—Syncope—Betamethasone—multiple sclerosis	0.000593	0.00151	CcSEcCtD
Terazosin—Syncope—Dexamethasone—multiple sclerosis	0.000593	0.00151	CcSEcCtD
Terazosin—Arrhythmia—Prednisone—multiple sclerosis	0.000591	0.0015	CcSEcCtD
Terazosin—Sweating—Methotrexate—multiple sclerosis	0.00059	0.0015	CcSEcCtD
Terazosin—Shock—Triamcinolone—multiple sclerosis	0.000585	0.00149	CcSEcCtD
Terazosin—Insomnia—Prednisolone—multiple sclerosis	0.000585	0.00149	CcSEcCtD
Terazosin—Shock—Methylprednisolone—multiple sclerosis	0.000584	0.00148	CcSEcCtD
Terazosin—Loss of consciousness—Betamethasone—multiple sclerosis	0.000581	0.00148	CcSEcCtD
Terazosin—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000581	0.00148	CcSEcCtD
Terazosin—Epistaxis—Methotrexate—multiple sclerosis	0.000581	0.00148	CcSEcCtD
Terazosin—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000581	0.00148	CcSEcCtD
Terazosin—Paraesthesia—Prednisolone—multiple sclerosis	0.000581	0.00148	CcSEcCtD
Terazosin—Tachycardia—Triamcinolone—multiple sclerosis	0.000581	0.00148	CcSEcCtD
Terazosin—Nausea—Azathioprine—multiple sclerosis	0.000579	0.00147	CcSEcCtD
Terazosin—Tachycardia—Methylprednisolone—multiple sclerosis	0.000579	0.00147	CcSEcCtD
Terazosin—Malnutrition—Prednisone—multiple sclerosis	0.000576	0.00146	CcSEcCtD
Terazosin—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000575	0.00146	CcSEcCtD
Terazosin—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000574	0.00146	CcSEcCtD
Terazosin—Convulsion—Dexamethasone—multiple sclerosis	0.000573	0.00146	CcSEcCtD
Terazosin—Convulsion—Betamethasone—multiple sclerosis	0.000573	0.00146	CcSEcCtD
Terazosin—Asthenia—Mitoxantrone—multiple sclerosis	0.000566	0.00144	CcSEcCtD
Terazosin—Myalgia—Betamethasone—multiple sclerosis	0.000563	0.00143	CcSEcCtD
Terazosin—Myalgia—Dexamethasone—multiple sclerosis	0.000563	0.00143	CcSEcCtD
Terazosin—Anxiety—Dexamethasone—multiple sclerosis	0.000561	0.00143	CcSEcCtD
Terazosin—Anxiety—Betamethasone—multiple sclerosis	0.000561	0.00143	CcSEcCtD
Terazosin—Discomfort—Dexamethasone—multiple sclerosis	0.000556	0.00141	CcSEcCtD
Terazosin—Discomfort—Betamethasone—multiple sclerosis	0.000556	0.00141	CcSEcCtD
Terazosin—Hypotension—Methylprednisolone—multiple sclerosis	0.000555	0.00141	CcSEcCtD
Terazosin—Pain—Prednisolone—multiple sclerosis	0.000553	0.00141	CcSEcCtD
Terazosin—Pharyngitis—Methotrexate—multiple sclerosis	0.000549	0.0014	CcSEcCtD
Terazosin—Vision blurred—Prednisone—multiple sclerosis	0.000543	0.00138	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000542	0.00138	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000541	0.00137	CcSEcCtD
Terazosin—Anaphylactic shock—Betamethasone—multiple sclerosis	0.00054	0.00137	CcSEcCtD
Terazosin—Oedema—Dexamethasone—multiple sclerosis	0.00054	0.00137	CcSEcCtD
Terazosin—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.00054	0.00137	CcSEcCtD
Terazosin—Oedema—Betamethasone—multiple sclerosis	0.00054	0.00137	CcSEcCtD
Terazosin—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000539	0.00137	CcSEcCtD
Terazosin—Insomnia—Triamcinolone—multiple sclerosis	0.000538	0.00137	CcSEcCtD
Terazosin—ABCB1—medulla oblongata—multiple sclerosis	0.000538	0.0111	CbGeAlD
Terazosin—Insomnia—Methylprednisolone—multiple sclerosis	0.000537	0.00136	CcSEcCtD
Terazosin—Ill-defined disorder—Prednisone—multiple sclerosis	0.000534	0.00136	CcSEcCtD
Terazosin—Paraesthesia—Triamcinolone—multiple sclerosis	0.000534	0.00136	CcSEcCtD
Terazosin—Feeling abnormal—Prednisolone—multiple sclerosis	0.000533	0.00136	CcSEcCtD
Terazosin—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000533	0.00136	CcSEcCtD
Terazosin—Visual impairment—Methotrexate—multiple sclerosis	0.000533	0.00135	CcSEcCtD
Terazosin—Shock—Dexamethasone—multiple sclerosis	0.000531	0.00135	CcSEcCtD
Terazosin—Shock—Betamethasone—multiple sclerosis	0.000531	0.00135	CcSEcCtD
Terazosin—Dyspnoea—Triamcinolone—multiple sclerosis	0.00053	0.00135	CcSEcCtD
Terazosin—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000528	0.00134	CcSEcCtD
Terazosin—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000528	0.00134	CcSEcCtD
Terazosin—Tachycardia—Dexamethasone—multiple sclerosis	0.000527	0.00134	CcSEcCtD
Terazosin—Tachycardia—Betamethasone—multiple sclerosis	0.000527	0.00134	CcSEcCtD
Terazosin—Angioedema—Prednisone—multiple sclerosis	0.000526	0.00134	CcSEcCtD
Terazosin—Dyspepsia—Triamcinolone—multiple sclerosis	0.000524	0.00133	CcSEcCtD
Terazosin—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000522	0.00133	CcSEcCtD
Terazosin—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000522	0.00133	CcSEcCtD
Terazosin—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000522	0.00133	CcSEcCtD
Terazosin—Malaise—Prednisone—multiple sclerosis	0.000519	0.00132	CcSEcCtD
Terazosin—Vertigo—Prednisone—multiple sclerosis	0.000517	0.00132	CcSEcCtD
Terazosin—Eye disorder—Methotrexate—multiple sclerosis	0.000517	0.00131	CcSEcCtD
Terazosin—Syncope—Prednisone—multiple sclerosis	0.000516	0.00131	CcSEcCtD
Terazosin—Tinnitus—Methotrexate—multiple sclerosis	0.000515	0.00131	CcSEcCtD
Terazosin—Anorexia—Betamethasone—multiple sclerosis	0.000514	0.00131	CcSEcCtD
Terazosin—Anorexia—Dexamethasone—multiple sclerosis	0.000514	0.00131	CcSEcCtD
Terazosin—Fatigue—Triamcinolone—multiple sclerosis	0.000513	0.0013	CcSEcCtD
Terazosin—Fatigue—Methylprednisolone—multiple sclerosis	0.000512	0.0013	CcSEcCtD
Terazosin—Pain—Triamcinolone—multiple sclerosis	0.000509	0.00129	CcSEcCtD
Terazosin—Loss of consciousness—Prednisone—multiple sclerosis	0.000506	0.00129	CcSEcCtD
Terazosin—Hypotension—Dexamethasone—multiple sclerosis	0.000504	0.00128	CcSEcCtD
Terazosin—Hypotension—Betamethasone—multiple sclerosis	0.000504	0.00128	CcSEcCtD
Terazosin—Vomiting—Mitoxantrone—multiple sclerosis	0.000501	0.00127	CcSEcCtD
Terazosin—Convulsion—Prednisone—multiple sclerosis	0.000499	0.00127	CcSEcCtD
Terazosin—Rash—Mitoxantrone—multiple sclerosis	0.000497	0.00126	CcSEcCtD
Terazosin—Dermatitis—Mitoxantrone—multiple sclerosis	0.000497	0.00126	CcSEcCtD
Terazosin—Headache—Mitoxantrone—multiple sclerosis	0.000494	0.00126	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000492	0.00125	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000492	0.00125	CcSEcCtD
Terazosin—ABCB1—midbrain—multiple sclerosis	0.000492	0.0101	CbGeAlD
Terazosin—Myalgia—Prednisone—multiple sclerosis	0.00049	0.00125	CcSEcCtD
Terazosin—Arthralgia—Prednisone—multiple sclerosis	0.00049	0.00125	CcSEcCtD
Terazosin—Feeling abnormal—Triamcinolone—multiple sclerosis	0.00049	0.00125	CcSEcCtD
Terazosin—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000489	0.00124	CcSEcCtD
Terazosin—Anxiety—Prednisone—multiple sclerosis	0.000489	0.00124	CcSEcCtD
Terazosin—Insomnia—Betamethasone—multiple sclerosis	0.000488	0.00124	CcSEcCtD
Terazosin—Insomnia—Dexamethasone—multiple sclerosis	0.000488	0.00124	CcSEcCtD
Terazosin—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000485	0.00123	CcSEcCtD
Terazosin—Paraesthesia—Dexamethasone—multiple sclerosis	0.000485	0.00123	CcSEcCtD
Terazosin—Paraesthesia—Betamethasone—multiple sclerosis	0.000485	0.00123	CcSEcCtD
Terazosin—Discomfort—Prednisone—multiple sclerosis	0.000484	0.00123	CcSEcCtD
Terazosin—Malnutrition—Methotrexate—multiple sclerosis	0.000481	0.00122	CcSEcCtD
Terazosin—ABCB1—spinal cord—multiple sclerosis	0.00048	0.00986	CbGeAlD
Terazosin—Hypersensitivity—Prednisolone—multiple sclerosis	0.000477	0.00121	CcSEcCtD
Terazosin—Dyspepsia—Betamethasone—multiple sclerosis	0.000475	0.00121	CcSEcCtD
Terazosin—Dyspepsia—Dexamethasone—multiple sclerosis	0.000475	0.00121	CcSEcCtD
Terazosin—Dysgeusia—Methotrexate—multiple sclerosis	0.000471	0.0012	CcSEcCtD
Terazosin—Body temperature increased—Triamcinolone—multiple sclerosis	0.00047	0.0012	CcSEcCtD
Terazosin—Oedema—Prednisone—multiple sclerosis	0.00047	0.0012	CcSEcCtD
Terazosin—Anaphylactic shock—Prednisone—multiple sclerosis	0.00047	0.0012	CcSEcCtD
Terazosin—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000469	0.00119	CcSEcCtD
Terazosin—Decreased appetite—Dexamethasone—multiple sclerosis	0.000469	0.00119	CcSEcCtD
Terazosin—Decreased appetite—Betamethasone—multiple sclerosis	0.000469	0.00119	CcSEcCtD
Terazosin—Nausea—Mitoxantrone—multiple sclerosis	0.000468	0.00119	CcSEcCtD
Terazosin—Back pain—Methotrexate—multiple sclerosis	0.000466	0.00118	CcSEcCtD
Terazosin—Fatigue—Betamethasone—multiple sclerosis	0.000465	0.00118	CcSEcCtD
Terazosin—Fatigue—Dexamethasone—multiple sclerosis	0.000465	0.00118	CcSEcCtD
Terazosin—Shock—Prednisone—multiple sclerosis	0.000462	0.00118	CcSEcCtD
Terazosin—Pain—Dexamethasone—multiple sclerosis	0.000462	0.00117	CcSEcCtD
Terazosin—Pain—Betamethasone—multiple sclerosis	0.000462	0.00117	CcSEcCtD
Terazosin—Tachycardia—Prednisone—multiple sclerosis	0.000459	0.00117	CcSEcCtD
Terazosin—Hyperhidrosis—Prednisone—multiple sclerosis	0.000454	0.00116	CcSEcCtD
Terazosin—Vision blurred—Methotrexate—multiple sclerosis	0.000454	0.00115	CcSEcCtD
Terazosin—Anorexia—Prednisone—multiple sclerosis	0.000448	0.00114	CcSEcCtD
Terazosin—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000447	0.00114	CcSEcCtD
Terazosin—Feeling abnormal—Betamethasone—multiple sclerosis	0.000445	0.00113	CcSEcCtD
Terazosin—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000445	0.00113	CcSEcCtD
Terazosin—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000441	0.00112	CcSEcCtD
Terazosin—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000441	0.00112	CcSEcCtD
Terazosin—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000438	0.00111	CcSEcCtD
Terazosin—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000437	0.00111	CcSEcCtD
Terazosin—Malaise—Methotrexate—multiple sclerosis	0.000434	0.0011	CcSEcCtD
Terazosin—Vertigo—Methotrexate—multiple sclerosis	0.000432	0.0011	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000428	0.00109	CcSEcCtD
Terazosin—Dizziness—Prednisolone—multiple sclerosis	0.000428	0.00109	CcSEcCtD
Terazosin—Asthenia—Triamcinolone—multiple sclerosis	0.000427	0.00109	CcSEcCtD
Terazosin—Abdominal pain—Dexamethasone—multiple sclerosis	0.000427	0.00108	CcSEcCtD
Terazosin—Abdominal pain—Betamethasone—multiple sclerosis	0.000427	0.00108	CcSEcCtD
Terazosin—Body temperature increased—Betamethasone—multiple sclerosis	0.000427	0.00108	CcSEcCtD
Terazosin—Body temperature increased—Dexamethasone—multiple sclerosis	0.000427	0.00108	CcSEcCtD
Terazosin—Asthenia—Methylprednisolone—multiple sclerosis	0.000426	0.00108	CcSEcCtD
Terazosin—Insomnia—Prednisone—multiple sclerosis	0.000425	0.00108	CcSEcCtD
Terazosin—Paraesthesia—Prednisone—multiple sclerosis	0.000422	0.00107	CcSEcCtD
Terazosin—Pruritus—Triamcinolone—multiple sclerosis	0.000421	0.00107	CcSEcCtD
Terazosin—Cough—Methotrexate—multiple sclerosis	0.00042	0.00107	CcSEcCtD
Terazosin—Pruritus—Methylprednisolone—multiple sclerosis	0.00042	0.00107	CcSEcCtD
Terazosin—Convulsion—Methotrexate—multiple sclerosis	0.000417	0.00106	CcSEcCtD
Terazosin—Dyspepsia—Prednisone—multiple sclerosis	0.000414	0.00105	CcSEcCtD
Terazosin—Chest pain—Methotrexate—multiple sclerosis	0.00041	0.00104	CcSEcCtD
Terazosin—Myalgia—Methotrexate—multiple sclerosis	0.00041	0.00104	CcSEcCtD
Terazosin—Arthralgia—Methotrexate—multiple sclerosis	0.00041	0.00104	CcSEcCtD
Terazosin—Decreased appetite—Prednisone—multiple sclerosis	0.000409	0.00104	CcSEcCtD
Terazosin—Rash—Prednisolone—multiple sclerosis	0.000408	0.00104	CcSEcCtD
Terazosin—Dermatitis—Prednisolone—multiple sclerosis	0.000407	0.00104	CcSEcCtD
Terazosin—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000406	0.00103	CcSEcCtD
Terazosin—Fatigue—Prednisone—multiple sclerosis	0.000405	0.00103	CcSEcCtD
Terazosin—Headache—Prednisolone—multiple sclerosis	0.000405	0.00103	CcSEcCtD
Terazosin—Discomfort—Methotrexate—multiple sclerosis	0.000405	0.00103	CcSEcCtD
Terazosin—ABCB1—nervous system—multiple sclerosis	0.000404	0.00831	CbGeAlD
Terazosin—Constipation—Prednisone—multiple sclerosis	0.000402	0.00102	CcSEcCtD
Terazosin—Confusional state—Methotrexate—multiple sclerosis	0.000396	0.00101	CcSEcCtD
Terazosin—Dizziness—Triamcinolone—multiple sclerosis	0.000393	0.001	CcSEcCtD
Terazosin—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000393	0.000999	CcSEcCtD
Terazosin—Dizziness—Methylprednisolone—multiple sclerosis	0.000392	0.000998	CcSEcCtD
Terazosin—ABCB1—central nervous system—multiple sclerosis	0.000389	0.008	CbGeAlD
Terazosin—Feeling abnormal—Prednisone—multiple sclerosis	0.000387	0.000985	CcSEcCtD
Terazosin—Asthenia—Dexamethasone—multiple sclerosis	0.000387	0.000985	CcSEcCtD
Terazosin—Asthenia—Betamethasone—multiple sclerosis	0.000387	0.000985	CcSEcCtD
Terazosin—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000385	0.000978	CcSEcCtD
Terazosin—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000384	0.000977	CcSEcCtD
Terazosin—Nausea—Prednisolone—multiple sclerosis	0.000384	0.000977	CcSEcCtD
Terazosin—Pruritus—Dexamethasone—multiple sclerosis	0.000382	0.000971	CcSEcCtD
Terazosin—Pruritus—Betamethasone—multiple sclerosis	0.000382	0.000971	CcSEcCtD
Terazosin—ABCB1—cerebellum—multiple sclerosis	0.00038	0.00782	CbGeAlD
Terazosin—Hyperhidrosis—Methotrexate—multiple sclerosis	0.00038	0.000966	CcSEcCtD
Terazosin—Vomiting—Triamcinolone—multiple sclerosis	0.000378	0.000962	CcSEcCtD
Terazosin—Vomiting—Methylprednisolone—multiple sclerosis	0.000377	0.00096	CcSEcCtD
Terazosin—Rash—Triamcinolone—multiple sclerosis	0.000375	0.000954	CcSEcCtD
Terazosin—Dermatitis—Triamcinolone—multiple sclerosis	0.000375	0.000953	CcSEcCtD
Terazosin—Anorexia—Methotrexate—multiple sclerosis	0.000374	0.000952	CcSEcCtD
Terazosin—Rash—Methylprednisolone—multiple sclerosis	0.000374	0.000952	CcSEcCtD
Terazosin—Dermatitis—Methylprednisolone—multiple sclerosis	0.000374	0.000951	CcSEcCtD
Terazosin—Headache—Triamcinolone—multiple sclerosis	0.000373	0.000948	CcSEcCtD
Terazosin—Headache—Methylprednisolone—multiple sclerosis	0.000372	0.000945	CcSEcCtD
Terazosin—Body temperature increased—Prednisone—multiple sclerosis	0.000372	0.000945	CcSEcCtD
Terazosin—Abdominal pain—Prednisone—multiple sclerosis	0.000372	0.000945	CcSEcCtD
Terazosin—Diarrhoea—Dexamethasone—multiple sclerosis	0.000369	0.000939	CcSEcCtD
Terazosin—Diarrhoea—Betamethasone—multiple sclerosis	0.000369	0.000939	CcSEcCtD
Terazosin—Hypotension—Methotrexate—multiple sclerosis	0.000367	0.000933	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000358	0.00091	CcSEcCtD
Terazosin—Dizziness—Dexamethasone—multiple sclerosis	0.000357	0.000908	CcSEcCtD
Terazosin—Dizziness—Betamethasone—multiple sclerosis	0.000357	0.000908	CcSEcCtD
Terazosin—Insomnia—Methotrexate—multiple sclerosis	0.000355	0.000903	CcSEcCtD
Terazosin—Nausea—Triamcinolone—multiple sclerosis	0.000353	0.000898	CcSEcCtD
Terazosin—Paraesthesia—Methotrexate—multiple sclerosis	0.000353	0.000897	CcSEcCtD
Terazosin—Nausea—Methylprednisolone—multiple sclerosis	0.000353	0.000896	CcSEcCtD
Terazosin—Dyspnoea—Methotrexate—multiple sclerosis	0.00035	0.000891	CcSEcCtD
Terazosin—Somnolence—Methotrexate—multiple sclerosis	0.000349	0.000888	CcSEcCtD
Terazosin—Hypersensitivity—Prednisone—multiple sclerosis	0.000346	0.000881	CcSEcCtD
Terazosin—Dyspepsia—Methotrexate—multiple sclerosis	0.000346	0.000879	CcSEcCtD
Terazosin—Vomiting—Dexamethasone—multiple sclerosis	0.000343	0.000873	CcSEcCtD
Terazosin—Vomiting—Betamethasone—multiple sclerosis	0.000343	0.000873	CcSEcCtD
Terazosin—Decreased appetite—Methotrexate—multiple sclerosis	0.000341	0.000868	CcSEcCtD
Terazosin—Rash—Betamethasone—multiple sclerosis	0.00034	0.000865	CcSEcCtD
Terazosin—Rash—Dexamethasone—multiple sclerosis	0.00034	0.000865	CcSEcCtD
Terazosin—Dermatitis—Betamethasone—multiple sclerosis	0.00034	0.000865	CcSEcCtD
Terazosin—Dermatitis—Dexamethasone—multiple sclerosis	0.00034	0.000865	CcSEcCtD
Terazosin—Fatigue—Methotrexate—multiple sclerosis	0.000339	0.000861	CcSEcCtD
Terazosin—Headache—Betamethasone—multiple sclerosis	0.000338	0.00086	CcSEcCtD
Terazosin—Headache—Dexamethasone—multiple sclerosis	0.000338	0.00086	CcSEcCtD
Terazosin—Asthenia—Prednisone—multiple sclerosis	0.000337	0.000858	CcSEcCtD
Terazosin—Pain—Methotrexate—multiple sclerosis	0.000336	0.000854	CcSEcCtD
Terazosin—Pruritus—Prednisone—multiple sclerosis	0.000333	0.000846	CcSEcCtD
Terazosin—Feeling abnormal—Methotrexate—multiple sclerosis	0.000324	0.000823	CcSEcCtD
Terazosin—Diarrhoea—Prednisone—multiple sclerosis	0.000322	0.000818	CcSEcCtD
Terazosin—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000321	0.000817	CcSEcCtD
Terazosin—Nausea—Dexamethasone—multiple sclerosis	0.000321	0.000815	CcSEcCtD
Terazosin—Nausea—Betamethasone—multiple sclerosis	0.000321	0.000815	CcSEcCtD
Terazosin—Dizziness—Prednisone—multiple sclerosis	0.000311	0.00079	CcSEcCtD
Terazosin—Body temperature increased—Methotrexate—multiple sclerosis	0.000311	0.00079	CcSEcCtD
Terazosin—Abdominal pain—Methotrexate—multiple sclerosis	0.000311	0.00079	CcSEcCtD
Terazosin—ABCB1—brain—multiple sclerosis	0.000309	0.00635	CbGeAlD
Terazosin—Vomiting—Prednisone—multiple sclerosis	0.000299	0.00076	CcSEcCtD
Terazosin—Rash—Prednisone—multiple sclerosis	0.000296	0.000754	CcSEcCtD
Terazosin—Dermatitis—Prednisone—multiple sclerosis	0.000296	0.000753	CcSEcCtD
Terazosin—Headache—Prednisone—multiple sclerosis	0.000294	0.000749	CcSEcCtD
Terazosin—Hypersensitivity—Methotrexate—multiple sclerosis	0.000289	0.000736	CcSEcCtD
Terazosin—Asthenia—Methotrexate—multiple sclerosis	0.000282	0.000717	CcSEcCtD
Terazosin—Nausea—Prednisone—multiple sclerosis	0.000279	0.00071	CcSEcCtD
Terazosin—Pruritus—Methotrexate—multiple sclerosis	0.000278	0.000707	CcSEcCtD
Terazosin—Diarrhoea—Methotrexate—multiple sclerosis	0.000269	0.000683	CcSEcCtD
Terazosin—Dizziness—Methotrexate—multiple sclerosis	0.00026	0.000661	CcSEcCtD
Terazosin—Vomiting—Methotrexate—multiple sclerosis	0.00025	0.000635	CcSEcCtD
Terazosin—Rash—Methotrexate—multiple sclerosis	0.000248	0.00063	CcSEcCtD
Terazosin—Dermatitis—Methotrexate—multiple sclerosis	0.000247	0.000629	CcSEcCtD
Terazosin—Headache—Methotrexate—multiple sclerosis	0.000246	0.000626	CcSEcCtD
Terazosin—Nausea—Methotrexate—multiple sclerosis	0.000233	0.000593	CcSEcCtD
Terazosin—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	0.000168	0.0011	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000167	0.0011	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—CNR1—multiple sclerosis	0.000164	0.00108	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—RGS1—multiple sclerosis	0.000164	0.00107	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—CXCR3—multiple sclerosis	0.000163	0.00107	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—RGS1—multiple sclerosis	0.00016	0.00105	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—CCR2—multiple sclerosis	0.000158	0.00104	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—TAGAP—multiple sclerosis	0.000157	0.00103	CbGpPWpGaD
Terazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000156	0.00103	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—CCR1—multiple sclerosis	0.000156	0.00103	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000156	0.00103	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—GPR65—multiple sclerosis	0.000155	0.00102	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—CCL5—multiple sclerosis	0.000154	0.00101	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—GPR65—multiple sclerosis	0.000152	0.000996	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000151	0.00099	CbGpPWpGaD
Terazosin—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	0.00015	0.000986	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—LINGO1—multiple sclerosis	0.00015	0.000985	CbGpPWpGaD
Terazosin—KCNH2—SIDS Susceptibility Pathways—IL6—multiple sclerosis	0.00015	0.000982	CbGpPWpGaD
Terazosin—ABCB1—Allograft Rejection—IL2—multiple sclerosis	0.00015	0.000982	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000149	0.000976	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—CXCL10—multiple sclerosis	0.000148	0.000972	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	0.000148	0.000971	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—CNR1—multiple sclerosis	0.000146	0.000959	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—RGS1—multiple sclerosis	0.000145	0.000954	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000144	0.000943	CbGpPWpGaD
Terazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000142	0.000932	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—CCR1—multiple sclerosis	0.000142	0.000932	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—CXCL13—multiple sclerosis	0.000142	0.000932	CbGpPWpGaD
Terazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.000141	0.000928	CbGpPWpGaD
Terazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000139	0.000912	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000139	0.000911	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—CCR1—multiple sclerosis	0.000139	0.000911	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—CCR5—multiple sclerosis	0.000138	0.000908	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—GPR65—multiple sclerosis	0.000138	0.000905	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—S1PR1—multiple sclerosis	0.000137	0.000899	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000134	0.000879	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—GPC5—multiple sclerosis	0.000133	0.000875	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—LINGO1—multiple sclerosis	0.000133	0.000875	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—CXCL10—multiple sclerosis	0.000132	0.000863	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—TAGAP—multiple sclerosis	0.00013	0.000854	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000129	0.000848	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—CCL5—multiple sclerosis	0.000127	0.000837	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	0.000127	0.000831	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CXCL13—multiple sclerosis	0.000126	0.000827	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CCR1—multiple sclerosis	0.000126	0.000827	CbGpPWpGaD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.000126	0.000824	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000125	0.000819	CbGpPWpGaD
Terazosin—KCNH2—Neuronal System—MAPK1—multiple sclerosis	0.000122	0.000803	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—CCL3—multiple sclerosis	0.000122	0.0008	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—CCR2—multiple sclerosis	0.000121	0.000796	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000118	0.000774	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—PTGER4—multiple sclerosis	0.000117	0.00077	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—SRM—multiple sclerosis	0.000117	0.000769	CbGpPWpGaD
Terazosin—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	0.000117	0.000766	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—RGS1—multiple sclerosis	0.000117	0.000765	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—TAGAP—multiple sclerosis	0.000116	0.000759	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000115	0.000757	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—CCR5—multiple sclerosis	0.000115	0.000754	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—S1PR1—multiple sclerosis	0.000114	0.000746	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000114	0.000745	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—CXCR3—multiple sclerosis	0.000113	0.000743	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—CCL5—multiple sclerosis	0.000113	0.000743	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—CNR1—multiple sclerosis	0.000112	0.000735	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—GPC5—multiple sclerosis	0.000111	0.000726	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—GPR65—multiple sclerosis	0.00011	0.000725	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—CCR2—multiple sclerosis	0.00011	0.000723	CbGpPWpGaD
Terazosin—ABCB1—Allograft Rejection—TNF—multiple sclerosis	0.000109	0.000715	CbGpPWpGaD
Terazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000108	0.000712	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—POMC—multiple sclerosis	0.000108	0.00071	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000107	0.000704	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—CCL2—multiple sclerosis	0.000106	0.000694	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000105	0.000687	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000104	0.00068	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000102	0.000672	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—CCR5—multiple sclerosis	0.000102	0.00067	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—CNR1—multiple sclerosis	0.000102	0.000667	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—CCL3—multiple sclerosis	0.000101	0.000664	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—S1PR1—multiple sclerosis	0.000101	0.000663	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CXCL13—multiple sclerosis	0.000101	0.000663	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CCR1—multiple sclerosis	0.000101	0.000663	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000101	0.000662	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—CCR2—multiple sclerosis	0.000101	0.000661	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.0001	0.000659	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—GPC5—multiple sclerosis	9.83e-05	0.000645	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—PTGER4—multiple sclerosis	9.74e-05	0.000639	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—RGS1—multiple sclerosis	9.67e-05	0.000635	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—PTGER4—multiple sclerosis	9.52e-05	0.000625	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—CXCR3—multiple sclerosis	9.4e-05	0.000617	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—CNR1—multiple sclerosis	9.3e-05	0.00061	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—CXCR3—multiple sclerosis	9.2e-05	0.000604	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—GPR65—multiple sclerosis	9.17e-05	0.000602	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—CXCL10—multiple sclerosis	9.16e-05	0.000601	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—CCR2—multiple sclerosis	9.15e-05	0.0006	CbGpPWpGaD
Terazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	9e-05	0.000591	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CCL3—multiple sclerosis	8.98e-05	0.00059	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—POMC—multiple sclerosis	8.98e-05	0.000589	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—CCR2—multiple sclerosis	8.95e-05	0.000587	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—CCL2—multiple sclerosis	8.78e-05	0.000576	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—CCL5—multiple sclerosis	8.68e-05	0.00057	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—PTGER4—multiple sclerosis	8.65e-05	0.000568	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—RGS1—multiple sclerosis	8.59e-05	0.000564	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—CNR1—multiple sclerosis	8.44e-05	0.000554	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CXCL13—multiple sclerosis	8.39e-05	0.00055	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CCR1—multiple sclerosis	8.39e-05	0.00055	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—CXCL10—multiple sclerosis	8.37e-05	0.000549	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CXCR3—multiple sclerosis	8.35e-05	0.000548	CbGpPWpGaD
Terazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	8.33e-05	0.000547	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—CNR1—multiple sclerosis	8.26e-05	0.000542	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CYP24A1—multiple sclerosis	8.26e-05	0.000542	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CYP27B1—multiple sclerosis	8.26e-05	0.000542	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—GPR65—multiple sclerosis	8.14e-05	0.000534	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CCR2—multiple sclerosis	8.13e-05	0.000533	CbGpPWpGaD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	8e-05	0.000525	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—POMC—multiple sclerosis	7.97e-05	0.000523	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—CCL5—multiple sclerosis	7.88e-05	0.000517	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—CCR5—multiple sclerosis	7.82e-05	0.000513	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—CCL2—multiple sclerosis	7.8e-05	0.000512	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—IL2RA—multiple sclerosis	7.71e-05	0.000506	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—CXCL10—multiple sclerosis	7.6e-05	0.000499	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GPC5—multiple sclerosis	7.55e-05	0.000496	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CNR1—multiple sclerosis	7.5e-05	0.000492	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CCR1—multiple sclerosis	7.45e-05	0.000489	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CXCL13—multiple sclerosis	7.45e-05	0.000489	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—CXCL10—multiple sclerosis	7.43e-05	0.000488	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—CCL5—multiple sclerosis	7.21e-05	0.000473	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CCL3—multiple sclerosis	7.2e-05	0.000472	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—CCR5—multiple sclerosis	7.1e-05	0.000466	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—IL2RA—multiple sclerosis	7e-05	0.000459	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PTGER4—multiple sclerosis	6.93e-05	0.000455	CbGpPWpGaD
Terazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	6.92e-05	0.000454	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PGR—multiple sclerosis	6.82e-05	0.000448	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CXCL10—multiple sclerosis	6.75e-05	0.000443	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CXCR3—multiple sclerosis	6.69e-05	0.000439	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CD28—multiple sclerosis	6.63e-05	0.000435	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—CCL5—multiple sclerosis	6.54e-05	0.000429	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CCR2—multiple sclerosis	6.51e-05	0.000427	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—CCR5—multiple sclerosis	6.49e-05	0.000426	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—CCL5—multiple sclerosis	6.4e-05	0.00042	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—IL2RA—multiple sclerosis	6.4e-05	0.00042	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—RRM1—multiple sclerosis	6.26e-05	0.000411	CbGpPWpGaD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	6.14e-05	0.000403	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—POMC—multiple sclerosis	6.11e-05	0.000401	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CNR1—multiple sclerosis	6.01e-05	0.000394	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CCL3—multiple sclerosis	5.98e-05	0.000392	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—CCR5—multiple sclerosis	5.89e-05	0.000387	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CCL5—multiple sclerosis	5.81e-05	0.000381	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—IL2RA—multiple sclerosis	5.81e-05	0.000381	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	5.77e-05	0.000379	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—CCR5—multiple sclerosis	5.77e-05	0.000378	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	5.76e-05	0.000378	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PTGER4—multiple sclerosis	5.75e-05	0.000377	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—IL2RA—multiple sclerosis	5.68e-05	0.000373	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PGR—multiple sclerosis	5.66e-05	0.000372	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	5.65e-05	0.000371	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CXCR3—multiple sclerosis	5.55e-05	0.000365	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—POMC—multiple sclerosis	5.55e-05	0.000364	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CD28—multiple sclerosis	5.5e-05	0.000361	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—CCL2—multiple sclerosis	5.43e-05	0.000356	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CXCL10—multiple sclerosis	5.41e-05	0.000355	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CCR2—multiple sclerosis	5.4e-05	0.000355	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	5.38e-05	0.000353	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CCL3—multiple sclerosis	5.31e-05	0.000348	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CCR5—multiple sclerosis	5.24e-05	0.000344	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—IL2RA—multiple sclerosis	5.16e-05	0.000339	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PTGER4—multiple sclerosis	5.11e-05	0.000335	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—POMC—multiple sclerosis	5.07e-05	0.000333	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PGR—multiple sclerosis	5.03e-05	0.00033	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CNR1—multiple sclerosis	4.99e-05	0.000327	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CXCR3—multiple sclerosis	4.93e-05	0.000324	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—TYK2—multiple sclerosis	4.93e-05	0.000324	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CD28—multiple sclerosis	4.89e-05	0.000321	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CCR2—multiple sclerosis	4.8e-05	0.000315	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CD86—multiple sclerosis	4.73e-05	0.00031	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CCL5—multiple sclerosis	4.66e-05	0.000306	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—POMC—multiple sclerosis	4.61e-05	0.000302	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—IL2—multiple sclerosis	4.52e-05	0.000297	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—CCL2—multiple sclerosis	4.51e-05	0.000296	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—POMC—multiple sclerosis	4.51e-05	0.000296	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CXCL10—multiple sclerosis	4.49e-05	0.000295	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CNR1—multiple sclerosis	4.43e-05	0.000291	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—SPP1—multiple sclerosis	4.31e-05	0.000283	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CCR5—multiple sclerosis	4.2e-05	0.000275	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IL2RA—multiple sclerosis	4.13e-05	0.000271	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—IL2—multiple sclerosis	4.1e-05	0.000269	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—TYK2—multiple sclerosis	4.09e-05	0.000269	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—POMC—multiple sclerosis	4.09e-05	0.000269	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CCL2—multiple sclerosis	4e-05	0.000263	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CXCL10—multiple sclerosis	3.99e-05	0.000262	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CD86—multiple sclerosis	3.93e-05	0.000258	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CCL5—multiple sclerosis	3.87e-05	0.000254	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—APOE—multiple sclerosis	3.82e-05	0.00025	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—IL2—multiple sclerosis	3.75e-05	0.000246	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—TYK2—multiple sclerosis	3.64e-05	0.000239	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.62e-05	0.000237	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—BCHE—multiple sclerosis	3.59e-05	0.000236	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—SPP1—multiple sclerosis	3.58e-05	0.000235	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CD86—multiple sclerosis	3.49e-05	0.000229	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CCR5—multiple sclerosis	3.48e-05	0.000229	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CD80—multiple sclerosis	3.45e-05	0.000226	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CCL5—multiple sclerosis	3.43e-05	0.000225	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IL2RA—multiple sclerosis	3.43e-05	0.000225	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—IL2—multiple sclerosis	3.41e-05	0.000223	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—IL2—multiple sclerosis	3.33e-05	0.000219	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—POMC—multiple sclerosis	3.28e-05	0.000215	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CCL2—multiple sclerosis	3.21e-05	0.000211	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—SPP1—multiple sclerosis	3.18e-05	0.000209	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—APOE—multiple sclerosis	3.17e-05	0.000208	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—MAPK1—multiple sclerosis	3.14e-05	0.000206	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CCR5—multiple sclerosis	3.09e-05	0.000203	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IL2RA—multiple sclerosis	3.05e-05	0.0002	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—IL2—multiple sclerosis	3.03e-05	0.000199	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—TYK2—multiple sclerosis	2.91e-05	0.000191	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CD80—multiple sclerosis	2.86e-05	0.000188	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—APOE—multiple sclerosis	2.81e-05	0.000185	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—POMC—multiple sclerosis	2.72e-05	0.000179	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CCL2—multiple sclerosis	2.66e-05	0.000175	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—MAPK1—multiple sclerosis	2.61e-05	0.000171	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CD80—multiple sclerosis	2.54e-05	0.000167	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IL2—multiple sclerosis	2.42e-05	0.000159	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—TYK2—multiple sclerosis	2.42e-05	0.000159	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—POMC—multiple sclerosis	2.42e-05	0.000159	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—IL6—multiple sclerosis	2.41e-05	0.000158	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CCL2—multiple sclerosis	2.37e-05	0.000155	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—MAPK1—multiple sclerosis	2.31e-05	0.000152	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MMP9—multiple sclerosis	2.29e-05	0.000151	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—APOE—multiple sclerosis	2.16e-05	0.000142	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—TYK2—multiple sclerosis	2.15e-05	0.000141	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—STAT3—multiple sclerosis	2.04e-05	0.000134	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IL2—multiple sclerosis	2.01e-05	0.000132	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—IL6—multiple sclerosis	2e-05	0.000131	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MMP9—multiple sclerosis	1.9e-05	0.000125	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MYC—multiple sclerosis	1.9e-05	0.000124	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—TGFB1—multiple sclerosis	1.89e-05	0.000124	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—POMC—multiple sclerosis	1.86e-05	0.000122	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MAPK1—multiple sclerosis	1.85e-05	0.000122	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IL2—multiple sclerosis	1.79e-05	0.000117	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—IL6—multiple sclerosis	1.78e-05	0.000117	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ALB—multiple sclerosis	1.69e-05	0.000111	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—STAT3—multiple sclerosis	1.69e-05	0.000111	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MMP9—multiple sclerosis	1.69e-05	0.000111	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MYC—multiple sclerosis	1.57e-05	0.000103	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—TGFB1—multiple sclerosis	1.57e-05	0.000103	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MAPK1—multiple sclerosis	1.54e-05	0.000101	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—STAT3—multiple sclerosis	1.5e-05	9.87e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IL6—multiple sclerosis	1.42e-05	9.35e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MYC—multiple sclerosis	1.4e-05	9.17e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—TGFB1—multiple sclerosis	1.39e-05	9.15e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MAPK1—multiple sclerosis	1.37e-05	8.97e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IL6—multiple sclerosis	1.18e-05	7.76e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IL6—multiple sclerosis	1.05e-05	6.89e-05	CbGpPWpGaD
